@article{e229a13e91be40f2821b68a478fb88a9,
title = "Current challenges in the management of nonsmall cell lung cancer brain metastases",
keywords = "RADIATION-THERAPY, BEVACIZUMAB, CONCURRENT, INHIBITORS, MELANOMA, SYSTEM, SAFETY",
author = "Hendriks, {Lizza E. L.} and Jacques Cadranel and Thierry Berghmans",
note = "Funding Information: Conflict of interest: L.E.L. Hendriks reports other funding from Boehringer Ingelheim, BMS, Roche, Lilly and BMS; grants from Roche, Boehringer Ingelheim; grants and other funding from AstraZeneca; personal fees from Quadia, outside the submitted work. J. Cadranel reports grants from AstraZeneca, Boehringer Ingelheim, Novartis and Pfizer; personal fees from AstraZeneca, Boehringer Ingelheim, BMS, Lilly, MSD, Novartis, Pfizer, Roche and Takeda, outside the submitted work. T. Berghmans has nothing to disclose.",
year = "2020",
month = jan,
day = "1",
doi = "10.1183/13993003.01686-2019",
language = "English",
volume = "55",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",
}